David M. Ross - Publications, H-index & Citations

David M. Ross

Royal Adelaide Hospital

37H指数

360论文数

7.0K被引数

收录论文 80

发表时间

Single cell long read genotyping of transcripts reveals discrete mechanisms of clonal evolution in post-MPN AML.单细胞长读长转录本基因分型揭示MPN后AML克隆进化的离散机制

Blood Advances

IF7.1

2026-05-12

OAAI

Julian Grabek; Jasmin Straube; Leanne Cooper; Rohit Haldar; Ranran Zhang; Inken Dulige; Matthew Barker; Will Gatehouse; Helen Christensen; Gerlinda Amor; Victoria Y. Ling; Caroline McNamara; David M. Ross; Andrew Perkins; Megan J. Bywater; Steven W. Lane

The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study 赖氨酸特异性去甲基化酶1（LSD1）抑制剂bomedemstat在骨髓纤维化中的应用：一项1/2期研究的结果

Blood Advances

IF7.1

2026-05-02

OAAI

Harinder Gill; Abdulraheem Yacoub; Aaron T. Gerds; Jake Shortt; James M. Rossetti; Adam J. Mead; Joachim R Göthert; Steffen Koschmieder; Joanne Ewing; Anna Halpern; Francesca Palandri; Francesco Passamonti; Ruben Mesa; Monia Marchetti; Claire Harrison; Alessandro M. Vannucchi; Justin M. Watts; John C. Wood; David M. Ross; Jennifer Peppe

Phase 2 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat for essential thrombocythemia LSD1（赖氨酸特异性去甲基化酶1）抑制剂bomedemstat治疗原发性血小板增多症的2期研究

Blood Advances

IF7.1

2026-03-03

OAAI

Harinder Gill; Francesca Palandri; David M. Ross; Joachim R. Göthert; Tara Cochrane; Stephen R. Larsen; Anna B. Halpern; Jake Shortt; James M. Rossetti; James Liang; Monia Marchetti; Andrew J. Wilson; Andrew J. Innes; Merit Hanna; Nicola Vianelli; William S. Stevenson; Alessandro M. Vannucchi; Maria Kleppe; Jessica Flynn; Georges Natsoulis

ICSH Recommendations for Monocyte Cell Lineage Morphologic Identification, Nomenclature Harmonization, and Utilization as a Biomarker ICSH关于单核细胞系形态学识别、命名协调及其作为生物标志物应用的建议

International Journal of Laboratory Hematology

IF2.3

2025-11-01

OAAI

Zini, Gina; Chang, Yoon Hwan; D'onofrio, Giuseppe; Frater, John; Germing, Ulrich; Merino, Anna; Pozdnyakova, Olga; Ross, David; Filho, Claudio Romulo Siqueira; Takami, Akiyoshi; Wendy, Erber

Clinical and biological predictors of treatment-free remission in CML CML治疗无药缓解的临床与生物学预测因子

LEUKEMIA & LYMPHOMA

IF2.2

2025-10-01

PREAI

Sutton, Edwina; Shanmuganathan, Naranie; Ross, David

Lipid Storage and Therapy Resistance in Chronic Myeloid Leukaemia: A Novel Perspective on Targeting Metabolic Vulnerabilities 脂质储存和治疗抵抗在慢性髓性白血病中的作用：靶向代谢脆弱性的新视角

Cancers 2025, Vol. 17, Page 3033

IF0

2025-09-23

OAAI

Molly Tolland; David M. Ross; Deborah White; Timothy P. Hughes; Ilaria S. Pagani

Granulocyte abundance and maturation state at diagnosis predicts treatment-free remission in CML 粒细胞数量和成熟状态在诊断时预测慢性粒细胞白血病的无治疗缓解。

Leukemia

IF13.4

2025-09-16

OAAI

Mikko Purhonen; Mikael Tatun; Katariina Luukkainen; Kevin Hung; Henri Sundquist; Oda Tafjord; Stina Söderlund; Shady Adnan-Awad; Anni Dohlen; Johanna Heikkinen; Perttu Koskenvesa; Sanna Siitonen; Satu Mustjoki; Naranie Shanmuganathan; Coral Bryce; Signe Danielsson; Henrik Hjorth-Hansen; Ulla Olsson-Strömberg; Takashi Kumagai; Shinya Kimura; David M. Ross; Oscar Brück

Impact of ASXL1 at diagnosis in CML patients receiving frontline potent TKIs: high risk of kinase domain mutations ASVL1在诊断时对接受一线强效TKI治疗的CML患者的影响：激酶域突变的高风险

Blood

IF23.1

2025-09-04

PREAI

Naranie Shanmuganathan; David T. Yeung; Carol Wadham; Adelina Fernandes; Muneeza Maqsood; NurHezrin Shahrin; Verity Saunders; Rosalie R. Kenyon; Ming Lin; John Toubia; Joe McConnell; Dominic Kaczorowski; David M. Ross; Agnes S. M. Yong; Lynette Chee; Jake Shortt; Nicholas Viiala; Jodi Braley; Chung Hoow Kok; Timothy P. Hughes

ADORE: an open platform study of ruxolitinib in combination with other novel therapies in patients with myelofibrosis ADORE：一项关于鲁索利替尼与其他新型疗法联合治疗骨髓纤维化患者的开放平台研究

Blood Advances

IF7.1

2025-05-09

OAAI

David M. Ross; Florian H. Heidel; Andrew Charles Perkins; Andreas Reiter; Carl Crodel; Caroline Riley; María Teresa Gómez-Casares; Istvan Takacs; Heiko Becker; Thomas Lehmann; Olga Vinogradova; Kate Burbury; Alessandro M. Vannucchi; Vikas Gupta; Marielle Wondergem; Jean-Jacques Kiladjian; Grace Cleary; Angela Zhang; Jagannath Kota; Anirudh Prahallad; Monika Wroclawska; Min Lu; Claire N. Harrison

The evolution of treatment-free remission 无治疗缓解的演变

BLOOD

IF23.1

2025-02-27

PREAI

Hughes, Timothy P.; Yong, Agnes S. M.; Ross, David M.

The β Common Cytokine Receptor Family Reveals New Functional Paradigms From Structural Complexities β共同细胞因子受体家族从结构复杂性中揭示新的功能范例

IMMUNOLOGICAL REVIEWS

IF8.3

2025-01-02

PREAI

Kan, Winnie L.; Weekley, Claire M.; Nero, Tracy L.; Hercus, Timothy R.; Yip, Kwok Ho; Tumes, Damon J.; Woodcock, Joanna M.; Ross, David M.; Thomas, Daniel; Teran, David; Owczarek, Catherine M.; Liu, Nora W.; Martelotto, Luciano G.; Polo, Jose M.; Pant, Harshita; Tvorogov, Denis; Lopez, Angel F.; Parker, Michael W.

High Dose Ascorbate Reduces Interleukin-1 Beta Secretion in TET2 Mutant Monocytes and Demonstrates Excellent and in CMML Patients in Combination with Azacitidine 高剂量抗坏血酸可降低TET2突变单核细胞中白细胞介素-1β的分泌，并在与阿扎胞苷联合使用时在CMML患者中显示出卓越效果。

BLOOD

IF23.1

2024-11-05

PREAI

Kamel, Maha M.; Robinson, Nirmal; Kutyna, Monika; Lim, Kelly; Thompson-Peach, Chloe; Lane, Steven W.; Yeung, David; Yong, Agnes S. M.; Ross, David M.; Hiwase, Devendra; Thomas, Daniel

CBL Variants in Chronic Myelomonocytic Leukemia Exhibit a Complex Sub-Clone Architecture with a High Frequency of RING Domain Mutations Sufficient to Induce GM-CSF Hypersensitivity CBL变体在慢性髓系单核细胞白血病中表现出复杂的亚克隆结构，并伴有高频RING结构域突变，足以诱导GM-CSF高敏感性。

BLOOD

IF23.1

2024-11-05

PREAI

Lim, Kelly; Kutyna, Monika; Kan, Winnie; Lopez, Angel F.; Brown, Anna; Yong, Agnes S. M.; Lane, Steven W.; Fong, Chun Yew; Hughes, Timothy P.; Yeung, David T.; Ross, David M.; Hiwase, Devendra; Thomas, Daniel

Improvements in Hematological Parameters and Quality of Life (QOL) with Elritercept (KER-050): Results from an Ongoing Phase 2 Trial in Participants with Lower-Risk (LR) Myelodysplastic Neoplasms (MDS)在Elritercept（KER-050）治疗下，血液学参数和生活质量（QOL）的改善：来自一项针对低风险（LR）骨髓异常增生性肿瘤（MDS）患者正在进行的2期试验的结果

BLOOD

IF23.1

2024-11-05

PREAI

Giagounidis, Aristoteles; Arnan, Monteserrat; Chee, Lynette C. Y.; Cluzeau, Thomas; Diez-Campelo, Maria; Hiwase, Devendra; Ross, David M.; Sekeres, Mikkael A.; Tan, Shuhying; Valcarcel, David; Buckstein, Rena; Patel-Shah, Bhavna; Yang, Ming; Jiang, Ying; Yin, Jiani; Bobba, Suresh; Hankin, Montagu; Materna, Chris; Graham, Christine; Thamake, Sanjay; Rovaldi, Christopher; Grayson, Dena; Salstrom, Jen L.

Computational Cytomorphological Analyses Identifies Bone Marrow Erythroblast Proportion As a Biomarker of Treatment-Free Remission in CML 计算细胞形态学分析将骨髓红细胞比例鉴定为CML治疗无复发的生物标志物

BLOOD

IF23.1

2024-11-05

PREAI

Purhonen, Mikko; Tatun, Mikael; Hung, Kevin; Tafjord, Oda; Adnan-Awad, Shady; Koskenvesa, Perttu; Siitonen, Sanna; Porkka, Kimmo; Mustjoki, Satu; Danielsson, Signe; Hjorth-Hansen, Henrik; Olsson-Stromberg, Ulla; Kumagai, Takashi; Kimura, Shinya; Ross, David M.; Bruck, Oscar E.

Dynamic Assessment of RBC-Transfusion Dependency (RBC-TD) Improves the Molecular International Prognostic 动态评估红细胞输注依赖性(RBC-TD)可改善分子国际预后评分系统

BLOOD

IF23.1

2024-11-05

PREAI

Wiseman, Thomas; Spooner, Michaela; Khanna, Shreyas; Hung, Kevin; Toop, Carla; Singhal, Deepak; Ross, David M.; Yeung, David; Brown, Anna; Scott, Hamish S.; Hahn, Christopher N.; Thomas, Daniel; Kok, Chung How; Hiwase, Devendra

A Phase 1/2 Study of Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor, in Combination with JAK Inhibitors Ruxolitinib or Momelotinib in Patients with Myelofibrosis 一项关于Nuvisertib（TP-3654）的1/2期研究，Nuvisertib是一种实验性选择性PIM1激酶抑制剂，与JAK抑制剂Ruxolitinib或Momelotinib联合用于骨髓纤维化患者。

BLOOD

IF23.1

2024-11-05

PREAI

Mascarenhas, John O.; Rampal, Raajit; El Chaer, Firas; Gupta, Vikas; Shimoda, Kazuya; Kiladjian, Jean-Jacques; Passamonti, Francesco; Bose, Prithviraj; Scandura, Joseph M.; Mesa, Ruben; Rein, Lindsay A. M.; Yuda, Junichiro; Ross, David M.; Devos, Timothy; Talpaz, Moshe; Hoffman, Ronald; Kabir, Sujan; Li, Zhonggai; Foulks, Jason M.; Ansaldo, Karen; Seki, Masataka; Peddagali, Vishnu; Shah, Jatin; Harrison, Claire

Single Cell Genotype-Phenotype Analysis Demonstrates That Post-MPN AML Is Driven By Clonal Evolution and Loss of Transcriptional Heterogeneity within Stem Cell Compartments 单细胞基因型-表型分析表明，MPN后AML是由克隆进化以及干细胞群内转录异质性的丧失所驱动。

BLOOD

IF23.1

2024-11-05

PREAI

Straube, Jasmin; Grabek, Julian; Cooper, Leanne; Haldar, Rohit; Mcnamara, Caroline; Ross, David M.; Perkins, Andrew; Bywater, Megan; Lane, Steven W.

Imatinib-Sensitive Chronic Myeloid Leukaemia Is Associated with mtDNA Mutations and Reduced Oxphos Capacity 伊马替尼敏感的慢性髓系白血病与mtDNA突变和降低的氧化磷酸化能力相关

BLOOD

IF23.1

2024-11-05

PREAI

Pagani, Ilaria Stefania; Krishnan, Vaidehi; Ouyang, John; Kok, Chung How; Chen, Beijun; Page, Elyse C.; Dang, Phuong; Saunders, Verity A.; James, Jane; Lim, Kelly; Shanmuganathan, Naranie; Branford, Susan; Chuah, Charles; Yeung, David T.; Thomas, Daniel; Hughes, Timothy P.; Ong, Sin Tiong; Ross, David M.

Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion

BLOOD ADVANCES

IF7.1

2024-06-27

PREAI

Venugopal, Parvathy; Arts, Peer; Fox, Lucy C.; Simons, Annet; Hiwase, Devendra K.; Bardy, Peter G.; Swift, Annette; Ross, David M.; van Vulpen, Lize F. D.; Buijs, Arjan; Bolton, Kelly L.; Getta, Bartlomiej; Furlong, Eliska; Carter, Tina; Krapels, Ingrid; Hoeks, Marlijn; Al Kindy, Adila; Al Kindy, Farah; de Munnik, Sonja; Evans, Pamela; Frank, Mahalia S. B.; Bournazos, Adam M.; Cooper, Sandra T.; Ha, Thuong Thi; Jackson, Matilda R.; Arriola-Martinez, Luis; Phillips, Kerry; Brennan, Yvonne; Bakshi, Madhura; Ambler, Karen; Gao, Song; Kassahn, Karin S.; Kenyon, Rosalie; Hung, Kevin; Babic, Milena; Mcgovern, Alan; Rawlings, Lesley; Vakulin, Cassandra; Dejong, Lucas; Fathi, Rema; Mcrae, Simon; Myles, Nicholas; Ladon, Dariusz; Jongmans, Marjolijn; Kuiper, Roland P.; Poplawski, Nicola K.; Barbaro, Pasquale; Blombery, Piers; Brown, Anna L.; Hahn, Christopher N.; Scott, Hamish S.

研究方向